Schubert & CO Regeneron Pharmaceuticals, Inc. Transaction History

Schubert & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$680.49 - $826.97 $680 - $826	1 Added 4.55%	23 $18,000
Q4 2022 Jan 31, 2023	BUY	$705.89 - $766.39 $2,823 - $3,065	4 Added 22.22%	22 $15,000
Q3 2022 Oct 21, 2022	BUY	$573.97 - $724.32 $1,147 - $1,448	2 Added 12.5%	18 $12,000
Q2 2022 Aug 01, 2022	BUY	$548.35 - $738.84 $3,838 - $5,171	7 Added 77.78%	16 $9,000
Q4 2021 Jan 28, 2022	BUY	$543.48 - $670.97 $4,891 - $6,038	9 New	9 $6,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.